Press Release

A USD 3 Billion Global Sarcopenia Treatment Market to Witness a CAGR of Around 4% During 2025-30

The Global Sarcopenia Treatment Market size was valued at around USD 3 billion in 2024 and is projected to reach USD 3.9 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 4% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The worldwide market for sarcopenia treatment is expanding significantly due to various important factors. The growing aged population globally is a major driver for market growth as they are much more likely to be afflicted by sarcopenia. Also, growing awareness of sarcopenia, especially in older adults is promoting early detection and treatment. As a result, patients and healthcare companies are taking proactive measures to manage aging-related muscle loss. Additionally, improvements in nutritional dietary supplements along with protein, vitamin D, and amino acids are important in the fight against sarcopenia. Increasingly doctors are prescribing these nutritional supplements to enhance muscular mass and power more comprehensive techniques for treatment. The market is also expanding due to government initiatives and healthcare programs aimed at assisting the aged populace.

Furthermore, efforts to find solutions for age-related issues like sarcopenia are being spurred by the increasing healthcare system, especially in developed countries. In addition, the rise in online pharmacies is expanding access to sarcopenia treatments making it easier for patients to acquire essential medications and supplements. Moreover, the market is expanding due to the growing healthcare in the region particularly in the Asia-Pacific due to growing urbanization and an aging population that increases demand for sarcopenia care. The efficacy of treatments is also being advanced by the improvement of targeted treatments that increase muscles and decrease infection.

Further, the growing number of elderly health applications that specialize in promoting healthy aging by integrating sarcopenia management into popular health initiatives. There's a growing need for treatments that can slow muscle loss as preventative healthcare becomes more crucial. Furthermore, there are options for treating sarcopenia with the growing popularity of nutraceuticals and functional foods which promotes market innovation. Together with improvements in treatment options, these factors are influencing the market growth & expansion of the sarcopenia treatment industry, further states the research report, “The Global Sarcopenia Treatment Market Analysis, 2025”.

Segmentation Analysis:

Protein supplements are the Most Preferred Treatment Type

Based on treatment type, the market is further bifurcated into Protein Supplements, Vitamin B12 Supplements, and Vitamin D and Calcium Supplements. Protein supplements directly help muscle health and prevent muscle loss, making it the market chief in the Global Sarcopenia Treatment Market accounting for nearly half of the market. Protein dietary supplements that are necessary for muscle growth were proven to help prevent or slow the development of sarcopenia especially in older adults. Due to the fact humans’ potential to synthesize protein from food decreases with age, protein supplements are required to preserve muscle tissue and power. Moreover, as older populations become more health conscious and understand the importance of maintaining muscle health, protein supplements have become a more popular choice. Protein supplement accessibility, availability, and proven efficacy help in generating more market demand for this segment.

North America Leads the Global Sarcopenia Treatment Industry

Geographically, North America has captured 40% of the entire market due to many factors such as the advanced healthcare system, aging population, and high levels of sarcopenia awareness. As the U.S. has the largest elderly population who often lose muscle mass, this demographic shift increases the demand for sarcopenia treatments. Furthermore, due to a strong healthcare system that facilitates access to therapies rehabilitation services, and diagnostic tools, North America has become stronger. Additionally, the region is supported by the presence of significant manufacturers of supplements and medications as well as continuous research and development in the field of treating sarcopenia. North America's dominance can also be attributed to healthcare regulations, public awareness campaigns, and an increasing emphasis on senior wellness.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Pfizer Inc., Yeast Zydus Cadila, Ltd, Angel Yeast, Makers Nutrition LLC, Metabolic Technologies Inc., Metagenics LLC, Haleon Group of Companies, Abbott Laboratories, Nestlé SA, Eli Lilly, Sanofi Inc., Novartis AG, Amway Corporation, Bayer AG, and Others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & solution adoption?
5. What key factors would propel and impede the industry across the regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?